Ascites News and Research

RSS
Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Cantrixil drug granted FDA Orphan Drug Designation for treatment of ovarian cancer

Novogen appoints PCG Advisory to manage investor-awareness program in the US

Novogen appoints PCG Advisory to manage investor-awareness program in the US

Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

Cantrixil proves highly effective at killing human ovarian stem cells in pre-clinical study

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Pre-clinical data on Novogen’s Cantrixil to be presented at two upcoming conferences

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Lilly receives FDA approval for CYRAMZA (ramucirumab)

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

Ashish Nimgaonkar wins AGA-Boston Scientific Career Development Technology & Innovation Award

Faster and more accurate method for testing new cancer drugs

Faster and more accurate method for testing new cancer drugs

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

FDA approves CYRAMZA in combination with paclitaxel for advanced adenocarcinoma

Innovative treatment option for children with plastic bronchitis

Innovative treatment option for children with plastic bronchitis

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Medac Pharma launches Rasuvo (methotrexate) injection for patients with RA, pJIA and psoriasis

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Medac Pharma's Rasuvo injection gets FDA approval for RA, pJIA and psoriasis

Telemedicine could improve quality of life of patients with chronic liver diseases

Telemedicine could improve quality of life of patients with chronic liver diseases

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Alcoholic liver disease: an interview with Dr Vinood Patel, University of Westminster

Fibrogen reports FG-3019 Phase 2 study results for treatment of pancreatic cancer

Fibrogen reports FG-3019 Phase 2 study results for treatment of pancreatic cancer

New research provides new hope for liver transplant patients with recurring hepatitis C

New research provides new hope for liver transplant patients with recurring hepatitis C

QUT researchers get new insight into ovarian cancer

QUT researchers get new insight into ovarian cancer

Novel device may simplify monitoring of patients' response to treatment for ovarian cancer

Novel device may simplify monitoring of patients' response to treatment for ovarian cancer

GlaxoSmithKline receives CHMP positive opinion for REVOLADE

GlaxoSmithKline receives CHMP positive opinion for REVOLADE